Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-02 1:04 pm Purchase |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
Atlas Venture Fund VII L P | 292,182 1.900% |
292,182 (New Position) |
Filing History |
| 2020-07-01 4:01 pm Sale |
2020-06-26 | 13D | Larimar Therapeutics, Inc. LRMR |
Flynn James E | 5,144,539 33.500% |
-946,711 (-15.54%) |
Filing History |
| 2020-06-30 4:46 pm Sale |
2020-06-26 | 13D | Larimar Therapeutics, Inc. LRMR |
CHONDRIAL THERAPEUTICS HOLDINGS LLC | 0 0.000% |
-6,091,250 (Position Closed) |
Filing History |
| 2020-06-11 5:07 pm Purchase |
2020-06-01 | 13G | Larimar Therapeutics, Inc. LRMR |
Vivo Capital IX, LLC | 653,779 4.300% |
653,779 (New Position) |
Filing History |
| 2020-06-08 5:21 pm Purchase |
2020-05-28 | 13D | Larimar Therapeutics, Inc. LRMR |
CHONDRIAL THERAPEUTICS HOLDINGS LLC | 6,091,250 39.800% |
6,091,250 (New Position) |
Filing History |
| 2020-06-08 5:10 pm Purchase |
2020-05-28 | 13D | Larimar Therapeutics, Inc. LRMR |
Flynn James E | 6,091,250 39.760% |
6,091,250 (New Position) |
Filing History |
| 2020-06-05 4:18 pm Purchase |
2020-06-02 | 13G | Larimar Therapeutics, Inc. LRMR |
HIRSCHMAN ORIN | 105,650 0.700% |
105,650 (New Position) |
Filing History |